Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02903030 · ClinicalTrials.gov registry record · Early Phase 1
Probiotics for Quality of Life in Autism Spectrum Disorders
A Early Phase 1 study of Anxiety and Autism Spectrum Disorders, sponsored by Ohio State University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT02903030 is a Early Phase 1 study of Anxiety and Autism Spectrum Disorders that has completed, run by Ohio State University. The registered enrollment target is 13 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02903030, a Early Phase 1 study of Anxiety and Autism Spectrum Disorders, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized pilot trial of a probiotic for quality of life in autism spectrum disorder (ASD), targeting gastrointestinal (GI) symptoms.
Conditions Studied
Interventions
- DRUG Maltose (placebo)
- DRUG Visbiome Extra Strength
Study Locations (1)
Ohio
- Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-12-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02903030
The ClinicalTrials.gov registry entry for NCT02903030 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (97% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Maltose (placebo) is the first listed.
NCT02903030 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02903030 about?
NCT02903030 is a clinical study titled "Probiotics for Quality of Life in Autism Spectrum Disorders". A randomized pilot trial of a probiotic for quality of life in autism spectrum disorder (ASD), targeting gastrointestinal (GI) symptoms.
What is the current status of trial NCT02903030?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 13 participants. The study started on 2016-08. Estimated completion is 2017-12-01.
What conditions does trial NCT02903030 study?
This clinical trial studies the following conditions: Anxiety, Autism Spectrum Disorders.
What interventions are being tested in trial NCT02903030?
The interventions under investigation include: Maltose (placebo) (DRUG), Visbiome Extra Strength (DRUG).
Who is sponsoring clinical trial NCT02903030?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02903030 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sleep, Dreaming, and Virtual Reality for Mental Health
RECRUITING · Early Phase 1
-
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
RECRUITING · Early Phase 1
-
Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia
RECRUITING · Early Phase 1
-
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
RECRUITING · Phase 4
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.